http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109988228-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-415 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-415 |
| filingDate | 2017-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109988228-B |
| titleOfInvention | A kind of astragalus mongolicus disease course-related protein and its crystal, growth method and application |
| abstract | The invention discloses Astragalus mongolicus disease course-related protein and its crystal, growth method and application. The disease course-related protein of Astragalus mongolica has the amino acid sequence described in any of the following (a)-(c): (a) is such as SEQ ID NO. The amino acid sequence shown in 1; (b) is an amino acid sequence having at least 90% homology with the amino acid sequence shown in SEQ ID NO.1; or (c) has the amino acid sequence shown in (a) or (b) Homologues, derivatives, fragments or mutants without losing biological activity; the present invention discloses the amino acid sequence of AmPR‑10 for the first time, which is beneficial to the identification and functional research of AmPR‑10, and it is further found that AmPR‑10 is in The use in the preparation of medicines for treating idiopathic pulmonary fibrosis, AmPR-10 has obvious therapeutic effects, and as a natural Chinese herbal medicine extract, it has wide sources and low toxicity, and is suitable for clinical application. |
| priorityDate | 2017-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 274.